A
Anthony Ogawa
Researcher at Merck & Co.
Publications - 27
Citations - 1068
Anthony Ogawa is an academic researcher from Merck & Co.. The author has contributed to research in topics: Glycogen phosphorylase & Mineralocorticoid receptor. The author has an hindex of 12, co-authored 27 publications receiving 977 citations.
Papers
More filters
Journal ArticleDOI
The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1).
Margarita Garcia-Calvo,JeanMarie Lisnock,Herbert G. Bull,Brian E. Hawes,Duane A. Burnett,Matthew P. Braun,James H. Crona,Harry R. Davis,Dennis C. Dean,Patricia A. Detmers,Michael P. Graziano,Meredith Hughes,D. Euan MacIntyre,Anthony Ogawa,Kim O’Neill,Sai Prasad N Iyer,Diane E. Shevell,Marsha Smith,Yui S. Tang,Amanda M. Makarewicz,Feroze Ujjainwalla,Scott W. Altmann,Kevin T. Chapman,Nancy A. Thornberry +23 more
TL;DR: A binding assay is developed and shown that labeled ezetimibe glucuronide binds specifically to a single site in brush border membranes and to human embryonic kidney 293 cells expressing NPC1L1, which unequivocally establish NPC1 L1 as the direct target of ezETimibe and should facilitate efforts to identify the molecular mechanism of cholesterol transport.
Journal ArticleDOI
A small-molecule inhibitor of BamA impervious to efflux and the outer membrane permeability barrier.
Elizabeth M. Hart,Angela M. Mitchell,Anna Konovalova,Anna Konovalova,Marcin Grabowicz,Marcin Grabowicz,Jessica Ruolin Sheng,Xiaoqing Han,Frances P. Rodriguez-Rivera,Adam G. Schwaid,Juliana C. Malinverni,Carl J. Balibar,Smaranda Bodea,Qian Si,Hao Wang,Michelle F. Homsher,Ronald E. Painter,Anthony Ogawa,Holly A. Sutterlin,Terry Roemer,Todd A. Black,Deborah M. Rothman,Scott S. Walker,Thomas J. Silhavy +23 more
TL;DR: A small molecule that inhibits OMP biogenesis at the cell surface represents a distinct class of antibacterial agents and possesses a second mechanism of action that kills gram-positive organisms.
Journal ArticleDOI
Glucose-lowering in a db/db mouse model by dihydropyridine diacid glycogen phosphorylase inhibitors.
Anthony Ogawa,Christopher A. Willoughby,Raynald Bergeron,Kenneth P. Ellsworth,Wayne M. Geissler,Robert W. Myers,Jun Yao,Georgianna Harris,Kevin T. Chapman +8 more
TL;DR: The synthesis of a series of novel dihdyropyridine diacid glycogen phosphorylase inhibitors is presented and SAR and functional assay data are discussed, along with the effect of a single inhibitor on blood glucose in a diabetic animal model.
Journal ArticleDOI
Novel 3,4-Dihydroquinolin-2(1H)-one inhibitors of human glycogen phosphorylase a
Keith G. Rosauer,Anthony Ogawa,Christopher A. Willoughby,Kenneth P. Ellsworth,Wayne M. Geissler,Robert W. Myers,Qiaolin Deng,Kevin T. Chapman,Georgianna Harris,David E. Moller +9 more
TL;DR: The preparation of a series of substituted indoles coupled to six- and seven-membered cyclic lactams is described and their role as human glycogen phosphorylase a inhibitors discussed and the SAR of the indole moiety and lactam ring are presented.
Patent
Mineralocorticoid receptor antagonists
Alejandro Crespo,Ping Lan,Rudrajit Mal,Anthony Ogawa,Hong C. Shen,Peter J. Sinclair,Zhongxiang Sun,Ellen K. Vande Bunte,Zhicai Wu,Kun Liu,Robert J. DeVita,Dong-Ming Shen,Min Shu,John Qiang Tan,Changhe Qi,Yuguang Wang,Richard Beresis +16 more
TL;DR: In this paper, the compounds of the Formula (I) as well as pharmaceutically acceptable salts thereof, which are useful for treating aldosterone-mediated diseases, are disclosed.